In conclusion, AT SRA1 expression is elevated in people with obesity which associates with typical immunometabolic markers of obesity/T2D, implying that SRA1 may have potential as a biomarker of metabolic derangements. This evidence concerns the gene SRA1 and obesity due to melanocortin 4 receptor deficiency.